Literature DB >> 19811520

White matter abnormalities and dystonic motor disorder associated with mutations in the SLC16A2 gene.

Artemis D Gika1, Ata Siddiqui, Anthony J Hulse, Selvakumari Edward, Penny Fallon, Meriel E McEntagart, Wajanat Jan, Dragana Josifova, Tally Lerman-Sagie, James Drummond, Edward Thompson, Samuel Refetoff, Carsten G Bönnemann, Heinz Jungbluth.   

Abstract

AIM: Mutations in the SLC16A2 gene have been implicated in Allan-Herndon-Dudley syndrome (AHDS), an X-linked learning disability* syndrome associated with thyroid function test (TFT) abnormalities. Delayed myelination is a non-specific finding in individuals with learning disability whose genetic basis is often uncertain. The aim of this study was to describe neuroimaging findings and neurological features in males with SLC16A2 gene mutations.
METHOD: We reviewed brain magnetic resonance imaging (MRI) findings and neurological features in a cohort of five males aged between 1 year 6 months and 6 years (median 4y) from four families harbouring SLC16A2 gene mutations.
RESULTS: The participants presented aged between 4 and 9 months with initial hypotonia and subsequent spastic paraparesis with dystonic posturing and superimposed paroxysmal dyskinesias. Dystonic cerebral palsy was the most common initial clinical diagnosis, and AHDS was suspected only retrospectively, considering the characteristically abnormal thyroid function tests, with high serum tri-iodothyronine (T(3)), as the most consistent finding. Brain MRI showed absent or markedly delayed myelination in all five participants, prompting the suspicion of Pelizaeus-Merzbacher disease in one patient.
INTERPRETATION: Our findings indicate a consistent association between defective neuronal T(3) uptake and delayed myelination. SLC16A2 involvement should be considered in males with learning disability, an associated motor or movement disorder, and evidence of delayed myelination on brain MRI. Although dysmorphic features suggestive of AHDS are not always present, T(3) measurement is a reliable screening test.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811520      PMCID: PMC5800746          DOI: 10.1111/j.1469-8749.2009.03471.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  27 in total

1.  Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene.

Authors:  V Herzovich; E Vaiani; R Marino; G Dratler; J M Lazzati; S Tilitzky; P Ramirez; S Iorcansky; M A Rivarola; A Belgorosky
Journal:  Horm Res       Date:  2006-09-15

2.  X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype.

Authors:  Kenton R Holden; Oscar F Zuñiga; Melanie M May; Humberto Su; Marco R Molinero; R Curtis Rogers; Charles E Schwartz
Journal:  J Child Neurol       Date:  2005-10       Impact factor: 1.987

3.  Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism.

Authors:  Edith C H Friesema; George G J M Kuiper; Jurgen Jansen; Theo J Visser; Monique H A Kester
Journal:  Mol Endocrinol       Date:  2006-08-03

4.  X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene.

Authors:  Knut Brockmann; Alexandra M Dumitrescu; Thomas T Best; Folker Hanefeld; Samuel Refetoff
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

Review 5.  Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease.

Authors:  Laura Calzà; Mercedes Fernandez; Alessandro Giuliani; Giulia D'Intino; Stefania Pirondi; Sandra Sivilia; Michela Paradisi; Nadia Desordi; Luciana Giardino
Journal:  Brain Res Brain Res Rev       Date:  2005-01-26

6.  Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8.

Authors:  Marija Trajkovic; Theo J Visser; Jens Mittag; Sigrun Horn; Jan Lukas; Veerle M Darras; Genadij Raivich; Karl Bauer; Heike Heuer
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

7.  Invited article: an MRI-based approach to the diagnosis of white matter disorders.

Authors:  Raphael Schiffmann; Marjo S van der Knaap
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

8.  Severe nonspecific X-linked mental retardation caused by a proximally Xp located gene: intragenic heterogeneity or a new form of X-linked mental retardation?

Authors:  M R Passos-Bueno; B C Byth; S Rosenberg; R I Takata; E Bakker; A H Beggs; R C Pavanello; M Vainzof; K E Davies; M Zatz
Journal:  Am J Med Genet       Date:  1993-04-15

9.  Thyroid hormone participates in the regulation of neural stem cells and oligodendrocyte precursor cells in the central nervous system of adult rat.

Authors:  M Fernandez; S Pirondi; M Manservigi; L Giardino; L Calzà
Journal:  Eur J Neurosci       Date:  2004-10       Impact factor: 3.386

10.  Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.

Authors:  Catherine Vaurs-Barrière; Marlène Deville; Catherine Sarret; Geneviève Giraud; Vincent Des Portes; José-Maria Prats-Viñas; Giuseppe De Michele; Bernard Dan; Angela F Brady; Odile Boespflug-Tanguy; Renaud Touraine
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

View more
  24 in total

1.  Adeno Associated Virus 9-Based Gene Therapy Delivers a Functional Monocarboxylate Transporter 8, Improving Thyroid Hormone Availability to the Brain of Mct8-Deficient Mice.

Authors:  Hideyuki Iwayama; Xiao-Hui Liao; Lyndsey Braun; Soledad Bárez-López; Brian Kaspar; Roy E Weiss; Alexandra M Dumitrescu; Ana Guadaño-Ferraz; Samuel Refetoff
Journal:  Thyroid       Date:  2016-08-23       Impact factor: 6.568

2.  MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features.

Authors:  Davide Tonduti; Adeline Vanderver; Angela Berardinelli; Johanna L Schmidt; Christin D Collins; Francesca Novara; Antonia Di Genni; Alda Mita; Fabio Triulzi; Janice E Brunstrom-Hernandez; Orsetta Zuffardi; Umberto Balottin; Simona Orcesi
Journal:  J Child Neurol       Date:  2012-07-17       Impact factor: 1.987

Review 3.  Genetic updates on paroxysmal dyskinesias.

Authors:  James Y Liao; Philippe A Salles; Umar A Shuaib; Hubert H Fernandez
Journal:  J Neural Transm (Vienna)       Date:  2021-04-30       Impact factor: 3.575

Review 4.  Thyroid hormone transporters--functions and clinical implications.

Authors:  Juan Bernal; Ana Guadaño-Ferraz; Beatriz Morte
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

Review 5.  Antenatal prevention of cerebral palsy and childhood disability: is the impossible possible?

Authors:  Stacey J Ellery; Meredith Kelleher; Peta Grigsby; Irina Burd; Jan B Derks; Jon Hirst; Suzanne L Miller; Larry S Sherman; Mary Tolcos; David W Walker
Journal:  J Physiol       Date:  2018-07-21       Impact factor: 5.182

6.  Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro.

Authors:  Jördis Klose; Lu Li; Xiaohui Fan; Ellen Fritsche; Melanie Pahl; Farina Bendt; Ulrike Hübenthal; Christian Jüngst; Patrick Petzsch; Astrid Schauss; Karl Köhrer; Ping Chung Leung; Chi Chiu Wang; Katharina Koch; Julia Tigges
Journal:  Cell Biol Toxicol       Date:  2022-06-15       Impact factor: 6.691

Review 7.  Episodic movement disorders: from phenotype to genotype and back.

Authors:  Knut Brockmann
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

Review 8.  The syndromes of reduced sensitivity to thyroid hormone.

Authors:  Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Biochim Biophys Acta       Date:  2012-08-16

Review 9.  Inherited defects in thyroid hormone cell-membrane transport and metabolism.

Authors:  Jiao Fu; Alexandra M Dumitrescu
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-07-09       Impact factor: 4.690

10.  Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination.

Authors:  Daniela López-Espíndola; Carmen Morales-Bastos; Carmen Grijota-Martínez; Xiao-Hui Liao; Dorit Lev; Ella Sugo; Charles F Verge; Samuel Refetoff; Juan Bernal; Ana Guadaño-Ferraz
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.